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The World Health Organization (WHO) has declared the
current Ebola epidemic an international public health
emergency.1 The epidemic is concentrated in West Africa,
an area of the world with an already poor health infrastruc-
ture and with some of the worst health indicators globally.2
The WHO estimated Sierra Leone, one of the affected
countries, to have the highest maternal mortality rate in
the world, 1100 per 100 000 live births, equating to a life-
time risk of 1 in 21 women dying during childbirth.3
The provision of adequate maternity services in Sierra
Leone is a challenge at the best of times; however, in the
context of an Ebola epidemic there are unique challenges
in both appropriate diagnosis and safe treatment. Whereas
regular health services should continue to operate during
an epidemic, it is unclear how best to provide safe obstetric
interventions. In any humanitarian emergency it is esti-
mated that approximately 15% of pregnant women will
encounter a potentially life-threatening complication,4 it is
these women which pose the greatest challenges in diagno-
sis and treatment during the epidemic.
Ebola is highly infectious and is spread through contact
with human bodily fluids, including breast milk and sweat.
As women are often caretakers of the sick, and during
pregnancy are more likely to have recently attended a
health clinic, they are a high-risk group for exposure to,
and transmission of, Ebola. The mortality rate of infected
pregnant women is very high, with perinatal mortality
believed to approach 100%.5
Clinical diagnosis of Ebola is difficult: the history and
symptoms are often general, especially in the early stages,
and overlap with many other differential conditions (for
example malaria or typhoid). In obstetrics there is a large
crossover between the presentation of women with preg-
nancy complications and the alert symptoms for a
suspected Ebola case. Spontaneous miscarriage, bleeding
(including vaginal bleeding), abdominal pain, chest pain,
joint pain, vomiting, stillbirth/intrauterine fetal death
(IUFD), and fever are routinely encountered in isolation or
combination as part of obstetrical referral criteria. The
same symptoms can also form part of the ‘case definition’
for an Ebola alert, in particular when combined with a his-
tory of contact with Ebola (including suspicion) or atten-
dance at funerals.
Differentiating between a woman who presents with an
obstetric emergency, where prompt intervention is neces-
sary and potentially lifesaving, and a woman who is sus-
pected of having Ebola, where invasive procedures should
be absolutely limited, remains a major challenge in this
field. The current system used to identify suspected Ebola
patients relies on verbal history and temperature alone.
This takes place in a ‘triage’ area before entry to the unit is
permitted. Because of the associated hazards of close con-
tact with an infected individual, the stratification of risk
takes place before health workers consider performing
exposure-prone procedures or the patient mixes with other
inpatients; however, this method is not robust. The patient
history is often unclear, particularly for women who arrive
in extreme circumstances and may be unconscious or
bleeding profusely. Furthermore, the history is occasionally
not reported correctly out of fear by patients or their rela-
tives (for example, if they had been to a traditional birth
attendant before coming, or if they have attempted to ter-
minate the pregnancy). Finally, during the epidemic
patients may withhold contact histories out of fear of stig-
matisation, isolation, or refusal of treatment.
Suspected Ebola patients should be isolated first, and
then tested, taking high-level infection control precau-
tions. Because of poor infrastructure and limited access to
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appropriate laboratory services, a test result may take in
excess of 24 hours to be received. During this time a
woman and/or fetus that arrive alive may die, or their con-
dition may significantly worsen, whilst awaiting a result.
The overlap in diagnostic criteria, but with contradictory
treatment strategies, creates an ethical conundrum for the
obstetrician in an Ebola epidemic. Is it medically possible
to justify withholding lifesaving treatment to someone who
is suspected of having an infectious disease? Equally, can
one risk exposing healthcare staff, and other patients, by
admitting an individual who is suspected of having Ebola?
Obstetrics is considered to be one of the highest expo-
sure-prone medical specialties in any context. Healthcare
workers, equipment, and the general environment will fre-
quently be exposed to large quantities of blood, amniotic
fluid, urine, and faeces. Healthcare staff are a high-risk
group for Ebola transmission and mortality in all health-
care facilities: in this sense, obstetrics during an Ebola epi-
demic can be considered an extremely high-risk specialty.6
Operatively, obstetric surgeries are often performed
under stressful, emergency conditions in order to save lives.
They frequently involve large levels of blood loss, often
operating in difficult conditions visually (for example vagi-
nal operations with limited access, or when there is heavy
bleeding obscuring the surgical field). This predisposes sur-
gical staff to a high risk of splashes of blood (or other
bodily fluids) and needle-stick or scalpel injuries.
Personal protective equipment (PPE) is the standard pre-
caution used for all procedures in an Ebola epidemic. The
most restrictive clothing is reserved for suspected or con-
firmed cases. The practicality of using PPE during surgery
remains controversial. The combination of a difficult oper-
ation, heat, reduced sensation, and reduced vision under
layers of PPE can render it a hazard to safety as well as a
protector. For example, if goggles repeatedly become
misted over there is a higher risk of sharps injury. Within
the Ebola Management Centres it is recommended that
PPE should be worn for a maximum of 1 hour. Complex
procedures that take longer periods of time may diminish
the efficacy of the PPE, particularly face masks.7,8
Individuals without symptoms of Ebola are not thought
to be contagious in normal circumstances;9 however, when
considering obstetrics procedures alongside the high per-
sonal and public cost of occupational infection, there is
insufficient evidence to fully balance the exposure risks (for
example if a patient were to exhibit symptoms shortly after
a caesarean section). The pre-emptive testing of all patients
has been suggested; however, this would be artificially reas-
suring because of high false-negative rates in the asymp-
tomatic, incubating, or recovering patients, where viral
loads may be low but not absent.9 Furthermore the poly-
merase chain reaction in a pregnant woman who has sur-
vived Ebola, and is negative for the virus in her blood, can
remain positive with high viral loads in the amniotic fluid,
placenta and fetus and hence continue to be contagious.10
If healthcare workers were to become infected with Ebola
the knock-on effect may be the closure of the unit itself.
There is also the wider political fall-out of healthcare (par-
ticularly expatriate) workers contracting Ebola. The situa-
tion therefore does not allow for flexibility or any
risk-taking, as the consequences of a single error can be
wide-reaching and lasting.
Maternal mortality and morbidity is tragically high
within the Ebola-affected region. Although there will be a
group of women who die from Ebola during pregnancy,
there is likely to be a far higher number of women who
will suffer as an indirect result of the epidemic. The health
structures that were functioning are now deserted of staff
and patients. Healthcare staff have died from Ebola and
those surviving fear working in the current conditions,
resulting in their absence and in industrial action.11
It is well documented that high maternal mortality rates
are often caused by consecutive delays in recognition,
access, and receipt of treatment.12 Certainly, this remains a
significant issue in the affected region. The rumours and
fear that accompany Ebola have magnified these delays.
Stories of patients being isolated and then dying has fed
into conspiracy theories that health centres are actively
injecting patients with Ebola, or outright murdering them,
scaring the population away. Furthermore, attendance of
suspected or confirmed Ebola cases at a health centre
directly leads to a drop in patient attendance because of
fear of transmission. As a result women are presenting ever
later with obstetric emergencies, waiting until they are in a
critical state. This further challenges the system of triaging
patients, with the urgency to treat being directly opposed
to the time needed to identify Ebola suspects. The decision
on whether to isolate a woman or not is potentially a deci-
sion between life and death, for both the patient and the
health worker.
Obstetric interventions during an Ebola epidemic are
theoretically, practically, and ethically deeply challenging.
To deny an individual, let alone a population, adequate
access to health care is a violation of their universal human
rights.13 Meeting the maternal health needs in the region
whilst the epidemic is continuing will require continual
assessment of how the risk to healthcare workers can be
minimised, enabling them to safely continue providing life-
saving care for their patients.
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